Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Arthritis and Rheumatism
|
October 12, 2012
Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases
Kevin Haynes, Timothy Beukelman, Jeffrey R Curtis, et al.
The Journal of Urology
|
May 23, 2017
Clinical and Psychosocial Predictors of Urological Chronic Pelvic Pain Symptom Change in 1 Year: A Prospective Study from the MAPP Research Network
Bruce D Naliboff, Alisa J Stephens, H Henry Lai, et al.
Ophthalmology
|
December 25, 2009
Cyclosporine for ocular inflammatory diseases
R Oktay Kaçmaz, John H Kempen, Craig Newcomb, et al.
American Journal of Ophthalmology
|
August 19, 2008
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity
R Oktay Kaçmaz, John H Kempen, Craig Newcomb, et al.
Journal of Ocular Biology, Diseases, and Informatics
|
September 14, 2010
Ocular disease in patients with ANCA-positive vasculitis
Angela S Watkins, John H Kempen, Dongseok Choi, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
February 19, 2013
Minimally invasive approach provides at least equivalent results for surgical correction of mitral regurgitation: a propensity-matched comparison
Andrew B Goldstone, Pavan Atluri, Wilson Y Szeto, et al.
The British Journal of Ophthalmology
|
February 22, 2023
Long-term visual acuity outcomes following cataract surgery in eyes with ocular inflammatory disease
Sapna Gangaputra, Craig Newcomb, Rebecca Armour, et al.
American Journal of Ophthalmology
|
June 16, 2024
Incidence and Remission of Post-Surgical Cystoid Macular Edema Following Cataract Surgery in Eyes With Intraocular Inflammation
Sapna Gangaputra, Craig Newcomb, Gui-Shuang Ying, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2021
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer
Katelyn T Byrne, Courtney B Betts, Rosemarie Mick, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Arthritis and Rheumatism
|
October 12, 2012
Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases
Kevin Haynes, Timothy Beukelman, Jeffrey R Curtis, et al.
The Journal of Urology
|
May 23, 2017
Clinical and Psychosocial Predictors of Urological Chronic Pelvic Pain Symptom Change in 1 Year: A Prospective Study from the MAPP Research Network
Bruce D Naliboff, Alisa J Stephens, H Henry Lai, et al.
Ophthalmology
|
December 25, 2009
Cyclosporine for ocular inflammatory diseases
R Oktay Kaçmaz, John H Kempen, Craig Newcomb, et al.
American Journal of Ophthalmology
|
August 19, 2008
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity
R Oktay Kaçmaz, John H Kempen, Craig Newcomb, et al.
Journal of Ocular Biology, Diseases, and Informatics
|
September 14, 2010
Ocular disease in patients with ANCA-positive vasculitis
Angela S Watkins, John H Kempen, Dongseok Choi, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
February 19, 2013
Minimally invasive approach provides at least equivalent results for surgical correction of mitral regurgitation: a propensity-matched comparison
Andrew B Goldstone, Pavan Atluri, Wilson Y Szeto, et al.
The British Journal of Ophthalmology
|
February 22, 2023
Long-term visual acuity outcomes following cataract surgery in eyes with ocular inflammatory disease
Sapna Gangaputra, Craig Newcomb, Rebecca Armour, et al.
American Journal of Ophthalmology
|
June 16, 2024
Incidence and Remission of Post-Surgical Cystoid Macular Edema Following Cataract Surgery in Eyes With Intraocular Inflammation
Sapna Gangaputra, Craig Newcomb, Gui-Shuang Ying, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2021
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer
Katelyn T Byrne, Courtney B Betts, Rosemarie Mick, et al.
Page
of 4